InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

Current share price for RHT : $0.061 0.001 (1.67%)+

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2023 3:37PM $0.059 $0.061 risen by 3.39%
$29 Change of Director's Interest Notice 20 Oct 2023 6:48PM $0.058 $0.061 risen by 5.17%
$29 Application for quotation of securities - RHT 20 Oct 2023 6:47PM $0.058 $0.061 risen by 5.17%
$29 Notice of Annual General Meeting/Proxy Form 11 Oct 2023 7:47PM $0.071 $0.061 fallen by 14.08%
$29 Notification regarding unquoted securities - RHT 11 Oct 2023 7:29PM $0.071 $0.061 fallen by 14.08%
$29 Change of Director's Interest Notice - Travis Baroni 28 Sep 2023 5:11PM $0.080 $0.061 fallen by 23.75%
$29 Date of AGM & Closing Date for Director Nominations 28 Sep 2023 5:08PM $0.080 $0.061 fallen by 23.75%
$29 Change of Director's Interest Notice - Aaron Brinkworth 6 Sep 2023 1:34PM $0.066 $0.061 fallen by 7.58%
$29 Appointment of CFO 5 Sep 2023 10:33AM $0.062 $0.061 fallen by 1.61%
$29 Company Secretary Appointment/Resignation 1 Sep 2023 3:01PM $0.060 $0.061 risen by 1.67%
$29 Annual Report & Appendix 4E 30 Aug 2023 8:05AM $0.060 $0.061 risen by 1.67%
$29 Appendix 4G & Corporate Governance Statement 30 Aug 2023 8:04AM $0.060 $0.061 risen by 1.67%
$29 Resonance Contracted by Major Global Pharma 18 Aug 2023 10:15AM $0.065 $0.061 fallen by 6.15%
$29 Trading Halt 17 Aug 2023 9:19AM $0.065 $0.061 fallen by 6.15%
$29 Expiry of ATM Facility 1 Aug 2023 7:11PM $0.053 $0.061 risen by 15.09%
$29 Management Transition 31 Jul 2023 1:57PM $0.053 $0.061 risen by 15.09%
$29 Quarterly Activities/Appendix 4C Cash Flow Report 25 Jul 2023 10:54AM $0.053 $0.061 risen by 15.09%
$29 Receipt of R&D Tax Incentive Refund 30 Jun 2023 12:22PM $0.041 $0.061 risen by 48.78%
$29 Updated HepaFatSmart Cleared by US FDA 29 Jun 2023 11:04AM $0.042 $0.061 risen by 45.24%
$29 Management Transition 23 Jun 2023 8:18AM $0.040 $0.061 risen by 52.50%
$29 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 1:42PM $0.044 $0.061 risen by 38.64%
$29 Director Appointment & Appendix 3X 28 Mar 2023 8:09AM $0.042 $0.061 risen by 45.24%
$29 Change of Director's Interest Notice 22 Mar 2023 8:13AM $0.042 $0.061 risen by 45.24%
$29 Half Yearly Report and Accounts 28 Feb 2023 4:20PM $0.052 $0.061 risen by 17.31%
$29 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2023 10:31AM $0.053 $0.061 risen by 15.09%

101 - 125 of 532 results

Page 5 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.